“Molecular Docking Study of Gingkgo biloba Compounds as Potential Inhibitors of SARS-CoV-2” (2022) SCRIPTA SCORE Scientific Medical Journal, 4(1), pp. 30–43. doi:10.32734/scripta.v4i1.8399.